WAT
Waters Corporation
455.59
1 x 419.00
1 x 498.85
bid
ask
-
1.88
0.41%
1 @ 07:22 AM
454.00 -1.59 (0.35%)
Ytd19.95%
1y28.09%
449.09
day range
464.94
282.77
52 week range
465.36
Open459.48Prev Close457.47Low449.09High464.94Mkt Cap44.73B
Vol1.27MAvg Vol808.79KEPS3.95P/E115.34Forward P/E27.53
Beta1.15Short Ratio5.00Inst. Own101.97%DividendN/ADiv YieldN/A
Ex Div Date11-26Earning11-0350-d Avg423.33200-d Avg367.391yr Est465.86
Earning
DateForEstimateReportedSurprisesurprise %
2026-11-032026-104N/AN/AN/A
2026-08-042026-073.013.050.041.33%
2026-05-052026-042.312.70.3916.88%
2026-02-092025-124.514.530.020.44%
2025-11-042025-093.213.40.195.92%
2025-08-042025-062.942.950.010.34%
Upgrade / Downgrade
DateFirmActionFromTo
2026-10-13TD CowenUpgradeBuyBuy
2026-10-07BarclaysUpgradeOverweightOverweight
2026-10-01GuggenheimUpgradeBuyBuy
2026-09-21Goldman SachsUpgradeBuyBuy
2026-09-09UBSUpgradeNeutralBuy
2026-08-27Piper SandlerUpgradeNeutralOverweight
Profile
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Insider Holder
DateNameRelationQuantityDescription
2026-02-24BATRA UDITChief Executive Officer36.56KStock Award(Grant)
2026-02-24BENNETT JIANQINGOfficer7.24KStock Award(Grant)
2026-02-24CARPIO ROBERT L IIIOfficer3.62KStock Award(Grant)
2026-02-24CHAUBAL AMOLChief Financial Officer8.51KStock Award(Grant)
2026-03-05FEARON RICHARD HDirector3.30KPurchase
2026-02-24HUANG PEARL S.Director3.28KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.8.48M3.87B8.64%
2026-06-29Vanguard Capital Management LLC6.42M2.92B6.53%
2026-06-29Vanguard Portfolio Management LLC4.74M2.16B4.83%
2026-06-29Massachusetts Financial Services Co.4.63M2.11B4.71%
2026-06-29State Street Corporation4.38M2.00B4.46%
2026-06-29T. Rowe Price Investment Management, Inc.3.82M1.74B3.89%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.12M1.42B3.17%
2026-06-29VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.55M1.16B2.59%
2026-06-29VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.13M969.35M2.17%
2026-06-29T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App2.10M957.54M2.14%
2026-08-30iShares Trust-iShares Core S&P 500 ETF1.31M595.70M1.33%
2026-08-30Fidelity Concord Street Trust-Fidelity 500 Index Fund1.27M580.71M1.30%
Dividend
DividendDate
0.161996-11-26
Split
SplitDate
2 : 12000-08-28
2 : 11999-06-11